DR. DEVLIN & PARTNERS
RACECOURSE MEDICAL GROUP, RACECOURSE MEDICAL GROUP, SHANTALLOW HEALTH CENTRE, RACECOURSE ROAD, LONDONDERRY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | None | None | NA% | |
| HF 4 | 2011 | None | None | NA% | |
| HF 4 | 2012 | 5 | 5 | 100.0% | |
| HF 4 | 2013 | 6 | 6 | 100.0% | |
| HF004 | 2014 | 5 | 5 | 100.0% | |
| HF004 | 2015 | None | None | NA% | |
| HF004 | 2016 | 5 | 5 | 100.0% | |
| HF004 | 2017 | 5 | 5 | 100.0% | |
| HF004 | 2018 | None | None | NA% | |
| HF004 | 2019 | None | None | NA% | |
| HF004 | 2020 | None | None | NA% | |
| HF004 | 2021 | None | None | NA% |
